PITTSBURGH (AP) _ NeuBase Therapeutics, Inc. (NBSE) on Thursday reported a loss of $5.5 million in its fiscal second quarter.

On a per-share basis, the Pittsburgh-based company said it had a loss of 24 cents.

In the final minutes of trading on Thursday, the company's shares hit $4.64. A year ago, they were trading at $8.69.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NBSE at https://www.zacks.com/ap/NBSE

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News